Extension of U.S. Deferred Prosecution Agreements

By

Regulatory News | 21 Dec, 2018

Updated : 17:41

RNS Number : 3522L
Standard Chartered PLC
21 December 2018
 

Extension of the U.S. Deferred Prosecution Agreements

 

LONDON, 21 December 2018 - Further to the legal and regulatory disclosures in its half year report and its Q3 Interim Management Statement dated 31 October 2018, Standard Chartered PLC ("the Group") announces it has agreed to an extension of its US Deferred Prosecution Agreements ("DPAs") until 31 March 2019.

 

The Group entered into the DPAs with the US Department of Justice and the New York County District Attorney's Office in December 2012. The agreements were subsequently extended until 31 December 2018.  The terms of the extension of the DPAs are materially the same as the prior extensions, and include an extension of the term of the independent monitor until 31 March 2019.  This extension does not affect the 31 December 2018 expiration of the term of the monitor appointed by the New York State Department of Financial Services, announced by the Group on 21 November 2018.

 

The Group continues to co-operate fully with an investigation by the US authorities into historical conduct and controls issues, which was first disclosed in 2014. The vast majority of the issues under investigation pre-date 2012, and none occurred after 2014. The Group is engaged in constructive discussions with relevant authorities to resolve the investigation as soon as practicable.

 

The Group will provide a further update as circumstances warrant. 

 

For further information, please contact: 

 

Duncan Hall - Investor queries

duncan.hall@sc.com

+44 (0)20 7885 7765 

 

Julie Gibson - Media queries  julie.gibson@sc.com

+44 (0)20 7885 2434

 

END

 

 

 

 

 

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPGGQWPUPRGMG

Last news